611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
CDC Reverses COVID Test Guideline After ControversyAs Schools Reopen, Many Students, Staff Live With High-Risk Family MemberCOVID-19 Poses Added Risk for People With Addiction Disorders: StudyGetting a Hip Replacement? Choice of Hospital Can Be CrucialAlmost 90,000 Young American Adults Will Get Cancer This Year: ReportAnother Rapid COVID-19 Test Shows PromiseDetails Emerge on Unexplained Illness in AstraZeneca COVID Vaccine TrialRising Obesity Levels Put Americans at Risk During Pandemic: CDCMore Pets May Be Getting COVID-19 Than RealizedWildfire Smoke Poses Special Threat to People With AsthmaCOVID-19 Prevention Might Translate Into Record Low Flu Rates: CDCFor Stroke Survivors, Timely Rehab Has Been Jeopardized During PandemicCOVID-19 Has Taken a Toll on Organ DonationCOVID Conflicts Are Putting Big Strains on RelationshipsCoronavirus Vaccine Plan for Americans AnnouncedParkinson's Ups the Odds for Dangerous Falls, But Prevention Is KeyPregnant Women With COVID-19 at High Risk for ComplicationsCompanion Drug Might Help Prevent Kidney Complications of LupusAHA News: Making Sense of Cholesterol – the Good, the Bad and the DietaryDo Ordinary Eyeglasses Offer Protection Against COVID-19?Elevated Blood Clotting Factor Linked to Worse COVID-19 OutcomesParkinson's Drug Eyed as Treatment for Severe Macular DegenerationNew Drug Shows Promise in Preventing Severe COVIDSome Psoriasis Meds May Also Help Prevent Heart DiseaseSmall Study Supports Donor Plasma Therapy for Severe COVID-19Probiotic Might Help Ease Children's EczemaDeath From COVID-19 Very Rare for Americans 21 and Under: ReportEven Exercise May Not Ease Pandemic-Linked StressDoctors Should Watch for Punctured Lungs in COVID PatientsCould COVID-19 Someday Become Seasonal, Like Flu?Is Arthritis Pain Relief as Close as Your Spice Rack?Their Jobs May Put Black Americans at Greater COVID Risk'Flattening the Curve' Saves More Lives Than ThoughtFewer Kids May Be Carrying Coronavirus Without Symptoms Than Believed: StudyCOVID-19 Takes Heavy Toll on KidneysPoll Finds Pandemic Surge in Loneliness Among Older AdultsAstraZeneca COVID Vaccine Trial RestartsDonating Plasma Helps Fight Immune DisorderKids at 2 Utah Day Cares Easily Spread COVID to FamiliesCOVID Hits Young Adults Harder Than Thought: StudyAHA News: A Closer Look at COVID-19 and Heart Complications Among AthletesAt One Hospital, ICU Workers' PPE May Have Kept Coronavirus at BayBlood Pressure Meds Can Affect COVID-19 CareStudy Confirms Restaurants, Bars Are COVID Infection HotspotsHow One Hospital Kept COVID Transmissions at Nearly ZeroJust How Reliable Are COVID-19 Tests? Experts Weigh InUntreated High Blood Pressure a Growing Problem Among AmericansWest Coast Wildfires, COVID a Double Whammy to Lung HealthWho's Most Likely to Binge Eat Amid Pandemic?Colleges in 50 States Seeing COVID Cases on Campus
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

First Trial of Gene-Targeted Asthma Rx in Kids Shows Promise

HealthDay News
by -- Robert Preidt
Updated: Sep 8th 2020

new article illustration

TUESDAY, Sept. 8, 2020 (HealthDay News) -- Asthma treatments tailored to the genes of kids and teens could help improve control of their symptoms, new research suggests.

The study included 241 adolescents, aged 12 to 18, who were randomly selected to receive either traditional asthma treatment or "personalized medicine" -- treatment based on their individual genetics.

During a year of follow-up, those in the personalized medicine group who had a genetic difference in a receptor gene targeted by asthma treatments reported a better quality-of-life score. The score was based on their symptoms, whether their normal activities were limited by their asthma, and how their asthma made them feel.

While more research is needed, the findings suggest personalized treatment could better control asthma in young people, according to the researchers.

The study -- the first of its kind in children and teens -- was presented recently at a virtual meeting of the European Respiratory Society. Research presented at meetings should be considered preliminary until published in a peer-reviewed journal.

"These results are very promising because they show, for the first time, that it could be beneficial to test for certain genetic differences in children with asthma and select medication according to those differences," said study leader Somnath Mukhopadhyay. He is chair of pediatrics at Royal Alexandra Children's Hospital, Brighton and Sussex Medical School in East Sussex, U.K.

The approach is an important goal for respiratory research, said Christopher Brightling, chair of the European Respiratory Society Science Council, who reviewed the findings.

"In this study, researchers used genetic information that we know is linked to how well patients respond to some inhaler treatments. They found that making use of this genetic information improved the outcome for children with asthma," Brightling said in a European Respiratory Society news release.

Asthma is a common condition in children that causes coughing, wheezing and difficulty breathing. About 5.5 million children under 18 in the United States have asthma, according to the U.S. Centers for Disease Control and Prevention.

More information

The American Lung Association has more on asthma and children.